The Patent Finder
US

Surfactant-Free Water-Free Foamable Compositions, Breakable Foams and Gels and Their Uses

US 8,945,516 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Dec 28, 2023 (SWK Funding LLC).

Lapsed Feb 3, 2023 on the fee record · High confidence

Second maintenance fee unpaid; grace period ended.

Filed Sep 10, 2012 as application 13/499,501 · Granted Feb 3, 2015
Base term, 20 years from filing
Today
Lapsed Feb 3, 2023
2010 2030
Clock starts
Oct 1, 2010
No longer in force
Feb 3, 2023
Granted
Feb 3, 2015
Term would have run to
Oct 1, 2030
base term after the term ends fee events Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,618,081, US 8,865,139, US 8,871,184, to Oct 1, 2030. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
51
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to Oct 1, 2030: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 1, 2010, when application PCT/IB2010/002612, the earliest non-provisional in its chain, was filed (this one was filed Sep 10, 2012)Oct 1, 2030High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,618,081, US 8,865,139, US 8,871,184)resolves to Oct 1, 2030, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidlapsed Feb 3, 2023High confidence
Computed term endThe steps above, in orderFeb 3, 2023High confidence

Partial family

Application PCT/IB2010/002612PCT application
no patent term
no patent term
Application PCT/IB2010/002613PCT application
no patent term
no patent term
Application PCT/IB2010/002617PCT application
no patent term
no patent term
Application PCT/IB2020/002612PCT application
no patent term
no patent term
US 8,618,081In force
Oct 2030
Oct 2030
Application PCT/IB2011/001374PCT application
no patent term
no patent term
US 8,945,516this patent
Feb 2023
Feb 2023
US 10,029,013In force
Oct 2030
Oct 2030
8 of 51 applications in this family shown, earliest filings first. Partial: 6 of the 51 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 10, 2012
Reel 28929, frame 451
Tamarkin, Dov; Gazal, Elana; Papiashvili, Irakliy; Hazot, Yohan; Schuz, David; Keynan, RitaFoamix Ltd.Assignment of Assignor's Interest
Jul 30, 2014
Reel 33445, frame 249
Foamix Ltd.Foamix Pharmaceuticals Ltd.Change of Name
Jul 30, 2019
Reel 49912, frame 45
Foamix Pharmaceuticals Ltd.Perceptive Credit Holdings II, LPPatent Security Agreement
Nov 4, 2020
Reel 54306, frame 387
Foamix Pharmaceuticals Ltd.Vyne Pharmaceuticals Ltd.Change of Name
Feb 4, 2021
Reel 55215, frame 298
Vyne Pharmaceuticals Ltd.Vyne Therapeutics Inc.Assignment of Assignor's Interest
Feb 17, 2021
Reel 55326, frame 9
Vyne Therapeutics Inc.Perceptive Credit Holdings II, LPPatent Security Agreement
Sep 20, 2021
Reel 57544, frame 138
Perceptive Credit Holdings II, LPVyne Pharmaceuticals Ltd. (F/K/A Foamix Pharmaceuticals Ltd.)Release of Security Interest
Sep 20, 2021
Reel 57544, frame 708
Perceptive Credit Holdings II, LPVyne Therapeutics Inc. (F/K/A Menlo Therapeutics Inc. and Successor-in-Interest to Vyne Pharmaceuticals Ltd., F/K/A Foamix Pharmaceuticals Ltd.)Release of Security Interest
Dec 22, 2021
Reel 58463, frame 208
Vyne Therapeutics Inc.Vyne Pharmaceuticals Inc.Assignment of Assignor's Interest
Feb 1, 2022
Reel 58925, frame 568
Vyne Therapeutics Inc.; Vyne Pharmaceuticals Inc.Journey Medical CorporationAssignment of Assignor's Interest
Dec 28, 2023
Reel 66157, frame 79
Journey Medical Corporation; JG Pharma, Inc.SWK Funding LLCSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited